Get started
Award

201909

Funded outputs count: 10
Funder award ID: 201909
OpenAlex ID: G894920197
Maternal adverse childhood experiences and epigenetic aging in pediatric populations: a scoping review
2026 · Debjani Chanda, Munawar Hussain Soomro, et al. · Frontiers in Child and Adolescent Psychiatry
PDF
Maternal exposure to essential and non-essential metals and thyroid hormone status in a Canadian pregnancy cohort
2026 · Munawar Hussain Soomro, Gillian England-Mason, et al. · Environmental Research
PDF
Moving Mendelian Randomization From Traditional Risk Factors to Molecular Targets for Drug Development and Clinical Trials in Nephrology
2026 · Abigail J. Berube, Eryn Yu, et al. · Kidney International Reports
PDF
Spatial Multi-Omics Connect SHROOM3 and COL18A1 in Chronic Kidney Disease
2024 · Pukhraj S. Gaheer, Nikhil Uppal, et al. · medRxiv · 1
PDF
How Does ADPKD Severity Differ Between Family Members?
2024 · Klement C. Yeung, Elise Fryml, et al. · Kidney International Reports · 8
PDF
Basic Research Protocol: Exome Sequencing in Adults With Loin Pain Hematuria Syndrome: A Pilot Study
2023 · Aditi Sharma, Matthew B. Lanktree, et al. · Canadian Journal of Kidney Health and Disease · 1
PDF
Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593
2022 · Asher L. Brandt, Sumanta Garai, et al. · Frontiers in Pharmacology · 8
ACLY and CKD: A Mendelian Randomization Analysis
2022 · Pedrum Mohammadi-Shemirani, Michael Chong, et al. · Kidney International Reports · 9
PDF
Prenatal exposure to phthalates and peripheral blood and buccal epithelial DNA methylation in infants: An epigenome-wide association study
2022 · Gillian England-Mason, Sarah M. Merrill, et al. · Environment International · 32
PDF
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy
2021 · Sumanta Garai, Luciana M. Leo, et al. · Journal of Medicinal Chemistry · 37
Year
Topic